Effects of topical treatment with fenretinide (4-HPR) and plasma vitamin A levels in patients with actinic keratoses

Cancer Letters

Volumn 110, Issue 1-2, 1996, Pages 87-91

  Moglia, Daniele ^a   Formelli, Franca ^a   Baliva, Gianandrea ^b   Bono, Aldo ^a   Accetturi, Mariapia ^b   Nava, Maurizio ^a   De Palo, Giuseppe ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Cancer prevention; Fenretinide; Topical application

Indexed keywords

4 HPR; FENRETINIDE; RETINOID; RETINOL; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; MALE; NIGHT BLINDNESS; PATHOLOGY; PRECANCER; PRIORITY JOURNAL; RELAPSE; SKIN TOXICITY; TOPICAL DRUG ADMINISTRATION; VITAMIN BLOOD LEVEL;

ADMINISTRATION, TOPICAL; ADULT; ANTICARCINOGENIC AGENTS; FACIAL DERMATOSES; FEMALE; FENRETINIDE; HUMANS; KERATOSIS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; REMISSION INDUCTION; VITAMIN A;

EID: 0030596183     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04475-8     Document Type: Article

References (39)

1. [1] Marks, R., Rennie, G. and Selwood, T.S. (1988) The relationship of basal cell carcinomas and squamous cell carcinomas to solar keratoses, Arch. Dermatol., 124, 1039-1042.
2. [2] Sanderson, K.V. and Mackie, R. (1979) In: Textbook of Dermatology, 3rd edn., p. 2179, Editors: A. Rook, D.S. Wilkinson and F.J.G. Ebling. Blackwell Scientific, Oxford.
3. [3] Sober, A.J. and Burnstein, J.M. (1995) Precursor to skin cancer, Cancer, 75 (Suppl. 2), 645-650.
4. [4] Papa, C.M. (1989) Tretinoin therapy for precancerous skin, N. Engl. J. Med., 86, 361-365.
5. [5] Pearse, A.D. and Marks, R. (1977) Actinic keratoses and the epidermis, Br. J. Dermatol., 96, 1029-1031.
6. [6] Bendl, B.J. and Graham, J.H. (1971) New concepts on the origin of squamous cell carcinomas of the skin: solar (senile) keratosis with squamous cell carcinoma. A clinicopathologic and histochemical study, Proc. Natl. Cancer Conf., 6, 471-488.
7. [7] Marks, R., Rennie, G. and Selwood, T.S. (1988) Malignant transformation of solar keratoses to squamous cell carcinoma, Lancet, 1, 795-797.
8. [8] Marks, R., Foley, P., Goodman, G., Hage, B.H. and Selwood, T.S. (1986) Spontaneous remission of solar keratoses: the case for conservative management, Br. J. Dermatol., 115, 649-655.
9. [9] Wald, N., Idle, M., Boreham, J. and Bailey, A. (1980) Low serum vitamin A and subsequent risk of cancer: preliminary results of a prospective study, Lancet, 2, 813-815.
10. [10] Kark, J.D., Smith, A.H., Switzer, B.R. and Hames, C.G. (1981) Serum vitamin A (retinol) and cancer incidence in Evan County, Georgia. J. Natl. Cancer Inst., 66, 7-16.
11. [11] Show, J.C. and White, C.R. (1986) Treatment of multiple keratoacanthomas with oral isotretinoin, J. Am. Acad. Dermatol., 15, 1079-1082.
12. [12] Holydey, R.P., Reed, M.L., Dzubow, L.M. and Jhupack, J.L. (1980) Treatment of keratoacanthomas with oral 13-cis-retinoic acid, N. Engl. J. Med., 303, 560-562.
13. [13] Kramer, K.H., Di Giovanna, J.J., Moshell, A.N., Tarone, R.E. and Peck, G.L. (1988) Prevention of skin cancer in xeroderma pigmentation with the use of oral isotretinoin, N. Engl. J. Med., 318, 1633-1637.
14. [14] Lutzner, M.A. and Blanchet-Bordon, C. (1980) Oral retinoid treatment of human papillomavirus type 5 induced epidermodysplasia verruciformis, N. Engl. J. Med., 302, 1091.
15. [15] Kanerva, L.O., Johansson, E. and Niemi, K.M. (1985) Epidermodysplasia verruciformis: clinical and light-and-electron-microscopic observations during etretinoide therapy, Arch. Dermatol. Res., 278, 153-160.
16. [16] Kingston, T., Gaskel, S. and Marks, R. (1983) The effects of a novel potent oral retinoid (Ro 13-6298) in the treatment of multiple solar keratoses and squamous cell epithelioma, Eur. J. Cancer, 19, 1201-1205.
17. [17] Grupper, C.H. and Berretti, B. (1983) Cutaneous neoplasia and etretinate. In: Proceedings of the 13th International Congress of Chemotherapy, p. 201, 24-27. Editors: K.H. Spitzy., K. Carrer, and V.H. Egermann. Vienna, Austria.
18. [18] Moriarty, M., Dunn, J., Darragh, A. and Lambe, R. (1982) Etretinate in treatment of actinic keratoses: a double blind crossover study, Lancet, 1, 364-365.
19. [19] Watson, A.B. (1986) Preventative effect of etretinate therapy on multiple actinic keratoses, Cancer Detect. Prev., 9, 161-165.
20. [20] Bollag, W. and Ott, F. (1970) Retinoic acid: topical treatment of senile or actinic keratoses and basal cell carcinomas, Agents Actions, 1, 172-175.
21. [21] Belisario, J.C. (1972) Recent advances in topical cytotoxis therapy of skin cancer precancer. In: Melanoma and Skin Cancer. Proceedings of an International Cancer Conference, pp. 349-365. Sydney, Australia.
22. [22] Barranco, V.P., Olson, R.I. and Everett, M.A. (1970) Response of actinic keratoses to topical vitamin A acid, Cutis, 6, 681-684.
23. [23] Remy, W. and Stuttgen, G. (1974) Comparative topical treatments of basal cell carcinomas and senile keratoses with 5-fluorouracil, retinoic acid, and dinitrochlorobenzene sensitization, Dermatologica, 148, 72-81.
24. [24] Bollag, W. and Ott, F. (1975) Vitamin A acid in benign and malignant epithelial tumors of the skin, Acta Derm.-Venereol. Suppl. (Stockholm), 74, 163-166.
25. [25] Kligman, A.M. and Thorne, E.G. (1991) Topical therapy of actinic keratoses with tretinoin. In: Retinoids in Cutaneous Malignancy, pp. 66-73. Editor: R. Marks. Blackwell Scientific, Oxford.
26. [26] Hong, W.K. and Itri, L.M. I. Retinoids and human cancer. In: The Retinoids: Biology, Chemistry, and Medicine. 2nd edn., Ch. 15, pp. 597-630. Editors: M.B. Sporn, A.B. Roberts and DeW.S. Goodman. Raven Press, New York.
27. [27] Orfanos, C.E., Ehlert, R. and Gollnick, H. (1987) The retinoids: a review of their clinical pharmacology and therapeutic use, Drugs, 34, 459-503.
28. [28] Weinstein, G.D., Nigra, T.P., Pochi, P.E., Savi, R., Allom, A., Benik, K., Jeffes, E., Lufrano, L. and Thorne, E.G. (1991) Topical tretinoin for treatmeat of photodamaged skin: a multicenter study, Arch. Dermatol., 127, 659-665.
29. [29] Goldfarb, M.T., Ellis, C.N., Weiss, J.S. and Voorhees, J.I. (1989) Topical tretinoin therapy: its use in photoaged skin, J. Am. Acad. Dermatol., 21 (3Pt2), 645-650.
30. [30] Weiss, J.S., Ellis, C.N., Goldfarb, M.T. and Voorhees, J.I. (1990) Tretinoin therapy: practical aspects of evaluation and treatment, J. Int. Med. Res., 18 (Suppl. 3), 41C-48C.
31. [31] Tomb, R., Dolfus, A. and Couppie, P. (1992) Allergic contact dermatitis from tretinoin (in French), Ann. Dermatol. Venereol., 119, 761-764.
32. [32] Noble, S. and Wagstaff, A.J. (1995) Tretinoin: a review of its pharmacological properties and clinical efficacy in the topical treatment of photodamaged skin, Drugs Aging, 6, 479-496.
33. [33] De Palo, G. and Formelli, F. (1995) Risks and benefits of retinoids in the chemoprevention of cancer, Drug Safety, 13, 245-256.
34. [34] Formelli, F., Clerici, M., Campa, T., Di Mauro, M.G., Magni, A., Mascotti, G., Moglia, D., De Palo, G., Costa, A. and Veronesi, U. (1993) Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations, J. Clin. Oncol., 11, 2036-2042.
35. [35] Garry, P.J., Hunt, W.C., Bondrofchak, J.L., Vanderjagt, D. and Goodwin, J.S. (1987) Vitamin A intake and plasma retinol levels in healthy elderly men and women, Am. J. Clin. Nutr., 46, 989-994.
36. [36] Lever, L. and Marks, R. (1991) Topical retinoid treatment for skin cancer: a review, Skin Pharmacol., 4, 125-131.
37. [37] Modiano, M.R., Dalton, W.S., Lippman, S.M., Joffe, L., Booth, A.R. and Meyskens, F.L. (1990) Ocular toxic effects of fenretinide, J. Natl. Cancer Inst., 82, 1063.
38. [38] Costa, A., Malone, W., Perloff, M., Buranelli, F., Campa, T., Dossena, G., Mani, A., Pizzichetta, M., Andreoli, C., Del Vecchio, M., Formelli, F. and Barbieri, A. (1989) Tolerability of the synthetic retinoid fenretinide (4-HPR), Eur. J. Clin. Oncol., 25, 805-808.
39. [39] Shaefer, H. and Zesch, A. (1975) Penetration of vitamin A acid into human skin, Acta Derm.-Venereol. Suppl. (Stockholm), 74, 50-55.